In three cases of type IV osteogenesis imperfecta (OI), we identified unique point mutations in type I collagen α1 (I) cDNA. In two cases, the appearance of dimers indicated the presence of cysteine substitutions in the α1 (I) protein chain. Cyanogen bromide digestion localized these cross- links to CB8 and 3, respectively. In the third case, the overmodification pattern of the CNBr peptides was compatible with a substitution in the aa 123-402 region of either type I collagen chain. We identified a unique point mutation in each proband, which resulted in substitutions for glycine residues in a 300-aa region of the αl(I) helix, specifically, Gly to Ala at codon 220 (GGT→CT), Gly to Cys at codon 349 (GGT→TGT) and Gly to Cys at codon 523 (GGT→...
The molecular defects responsible for three cases of severe (type III) osteogenesis imperfecta (OI) ...
Cultured fibroblasts from a patient affected with a moderate form of osteogenesis imperfecta were de...
This report describes the biochemical investigations on six patients affected by a moderate form of ...
Type I collagen α1(I) glycine to serine substitutions, resulting from G-to-A mutations, were defined...
Osteogenesis imperfecta (OI) is a generalized disorder of connective tissue characterized by fragile...
Cultured skin fibroblasts from seven consecutive cases of lethal perinatal osteogenesis imperfecta (...
The majority of collagen mutations causing osteogenesis imperfecta (OI) are glycine substitutions th...
Skin fibroblasts grown from three individuals with osteogenesis imperfecta (OI) each synthesized a p...
Osteogenesis Imperfecta (OI) comprises a heterogeneous group of patients who share bone fragility an...
Osteogenesis imperfecta (OI) type IB is a rare subset of the mildest form of OI, clinically characte...
A single base mismatch was detected by a chemical cleavage method in heteroduplexes formed between p...
In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogene...
Osteogenesis Imperfecta (OI) is a heterogeneous group of inherited disorders characterized by increa...
In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogene...
Quantitative and qualitative abnormalities of collagen were observed in tissues and fibroblast cultu...
The molecular defects responsible for three cases of severe (type III) osteogenesis imperfecta (OI) ...
Cultured fibroblasts from a patient affected with a moderate form of osteogenesis imperfecta were de...
This report describes the biochemical investigations on six patients affected by a moderate form of ...
Type I collagen α1(I) glycine to serine substitutions, resulting from G-to-A mutations, were defined...
Osteogenesis imperfecta (OI) is a generalized disorder of connective tissue characterized by fragile...
Cultured skin fibroblasts from seven consecutive cases of lethal perinatal osteogenesis imperfecta (...
The majority of collagen mutations causing osteogenesis imperfecta (OI) are glycine substitutions th...
Skin fibroblasts grown from three individuals with osteogenesis imperfecta (OI) each synthesized a p...
Osteogenesis Imperfecta (OI) comprises a heterogeneous group of patients who share bone fragility an...
Osteogenesis imperfecta (OI) type IB is a rare subset of the mildest form of OI, clinically characte...
A single base mismatch was detected by a chemical cleavage method in heteroduplexes formed between p...
In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogene...
Osteogenesis Imperfecta (OI) is a heterogeneous group of inherited disorders characterized by increa...
In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogene...
Quantitative and qualitative abnormalities of collagen were observed in tissues and fibroblast cultu...
The molecular defects responsible for three cases of severe (type III) osteogenesis imperfecta (OI) ...
Cultured fibroblasts from a patient affected with a moderate form of osteogenesis imperfecta were de...
This report describes the biochemical investigations on six patients affected by a moderate form of ...